mutations and complex kar yotype. It follows a linear evolution through the CLL clone with the recurrent acquisition of CDKN2A Genetic susceptibility mechanisms. Most susceptibility loci map to non-coding areas of the genome, are largely located in Lively promoters or enhancers, and modify the bi